Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizoaffective Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00547118
What this trial is testing

The Effects of Rimonabant, on Weight and Metabolic Risk Factors

Who this might be right for
SchizophreniaSchizoaffective DisorderObesity+2 more
University of Maryland, Baltimore 17
Not applicableStudy completedNCT00514423
What this trial is testing

How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs

Who this might be right for
SchizophreniaSchizoaffective Disorder
Technical University of Munich 896
Not applicableLooking for participantsNCT07006935
What this trial is testing

REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)

Who this might be right for
SchizophreniaSchizo Affective DisorderSchizophreniform Disorders
Case Western Reserve University 30
Not applicableUnknownNCT04099940
What this trial is testing

Virtual Reality Avatar Therapy for People Hearing Voices

Who this might be right for
PsychosisSchizophreniaSchizo Affective Disorder+1 more
Psychiatric University Hospital, Zurich 100
Testing effectiveness (Phase 2)Ended earlyNCT01844726
What this trial is testing

Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness

Who this might be right for
Psychiatric IllnessHealthy
Northwestern University 44
Not applicableUnknownNCT06159322
What this trial is testing

Characterizing Response to Antipsychotics in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
The Royal Ottawa Mental Health Centre 40
Post-approval studies (Phase 4)Study completedNCT00202293
What this trial is testing

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Melbourne Health 83
Post-approval studies (Phase 4)Study completedNCT02199743
What this trial is testing

Lurasidone Effects on Tissue Glutamate in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Texas Southwestern Medical Center 35
Not applicableStudy completedNCT00339170
What this trial is testing

Cognitive Training and Enhanced Supported Employment in Schizophrenia

Who this might be right for
Schizophrenia
Yale University 98
Not applicableLooking for participantsNCT06911931
What this trial is testing

Visual Perception in Schizophrenia

Who this might be right for
Schizophrenia DisordersBipolar DisorderSchizo Affective Disorder
University of Rochester 84
Not applicableStudy completedNCT03880227
What this trial is testing

Improving Visual Attention in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
The University of Texas at Dallas 81
Testing effectiveness (Phase 2)Study completedNCT04512066
What this trial is testing

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 287
Not applicableUnknownNCT04123223
What this trial is testing

Comparing Cognitive Remediation Approaches for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Wesleyan University 135
Testing effectiveness (Phase 2)Study completedNCT01267188
What this trial is testing

Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 10
Early research (Phase 1)Study completedNCT05105542
What this trial is testing

M1 Schizophrenia PET Study

Who this might be right for
SchizophreniaSchizoaffective DisorderHealthy
Yale University 18
Testing effectiveness (Phase 2)WithdrawnNCT04054973
What this trial is testing

L-arginine Study for Persistent Symptoms of Schizophrenia

Who this might be right for
Schizo Affective DisorderSchizophrenia
University of Massachusetts, Worcester
Not applicableStudy completedNCT02360813
What this trial is testing

Cognitive Remediation Therapy Within a Secure Forensic Setting

Who this might be right for
SchizophreniaSchizoaffective DisorderCognitive Deficits
Central Mental Hospital 65
Not applicableStudy completedNCT05670197
What this trial is testing

Service User and Staff Views on Digital Remote Monitoring for Psychosis

Who this might be right for
PsychosisSchizophreniaSchizoaffective Disorder
Manchester Academic Health Science Centre 118
Early research (Phase 1)Study completedNCT01065597
What this trial is testing

Nonconvulsive Electrotherapy: a Proof-of-concept Trial

Who this might be right for
Depressive DisorderBipolar DisorderSchizoaffective Disorder
University of Maryland, College Park 13
Not applicableEnded earlyNCT06033326
What this trial is testing

Validation of the French Version of the Lithium Knowledge Test (LKT)

Who this might be right for
Patient Treated With Lithium, With Bipolar or Schizo-affective Disorder, Hospitalized in a Psychiatric Ward
University Hospital, Lille 22
Next Page